Serum Nrf2 Levels in Severe Traumatic Brain Injury Patients and Its Significance in Predicting 28‐Day Mortality
Brain and Behavior · 2025-11 · 15 (11)
DOI: 10.1002/brb3.70786 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Brain and Behavior, online erschienen am 21.11.2025. Verfasst von Gongjian Yin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Brain Injuries, Traumatic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The objective of this study was to examine the levels of serum Nrf2 in patients with severe traumatic brain injury (STBI) and assess its predictive value for 28‐day mortality.
Methods
This study prospectively observed 252 patients with STBI who were admitted to our ICU between January 2018 and April 2024. Serum samples were collected within 24 h of admission, and levels of nuclear factor erythroid 2‐related factor 2 (Nrf2) and inflammatory cytokines were measured using ELISA. Additionally, the mortality rate within 28 days after admission to the ICU was recorded.
Results
In this prospective observational study, based on the 28‐day mortality after admission to the ICU, the patients were categorized into two groups based on their outcomes: the survival group ( n = 184) and the deceased group ( n = 68). Compared to the survival group, the deceased group exhibited lower serum Nrf2 levels and higher IL‐6 and IL‐17 levels. Spearman correlation analysis revealed a negative correlation between serum Nrf2 levels and serum IL‐6, IL‐1β, and IL‐17 levels, while a positive correlation was observed between serum Nrf2 levels and GCS scores. The ROC curve indicated that serum Nrf2 could be used to predict the 28‐day mortality in patients with STBI. Finally, multivariate logistic regression analysis showed that serum Nrf2, IL‐6, and IL‐17 levels were independently associated with 28‐day mortality in STBI patients.
Conclusion
In conclusion, we observed significantly lower serum Nrf2 levels in deceased STBI patients compared to the survival group. Additionally, Nrf2 could be used as a potential marker to predict 28‐day mortality in STBI patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
ORCID-Profile: Yaoxing Mu
Zitieren
APA
Yin, G., & Mu, Y. (2025). Serum Nrf2 Levels in Severe Traumatic Brain Injury Patients and Its Significance in Predicting 28‐Day Mortality. Brain and Behavior, 15(11). https://doi.org/10.1002/brb3.70786
Vancouver
Yin G, Mu Y. Serum Nrf2 Levels in Severe Traumatic Brain Injury Patients and Its Significance in Predicting 28‐Day Mortality. Brain and Behavior. 2025;15(11). doi:10.1002/brb3.70786
BibTeX
@article{Yin2025,
author = {Yin, Gongjian and Mu, Yaoxing},
title = {Serum Nrf2 Levels in Severe Traumatic Brain Injury Patients and Its Significance in Predicting 28‐Day Mortality},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {11},
doi = {10.1002/brb3.70786}
}
EUVIMED